treatment of overactive bladder

Phase 3

Recruiting

Conditions: Over Active Bladder.
Overactive bladder
N32.81

Registration Number: IRCT20151123025202N4

Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 74

Inclusion Criteria

Clinical Diagnosis of overactive bladder
minimum age of 18 years old
negative result of Urine culture

Exclusion Criteria

pregnant women
People with Pacemaker
Inflammatory or neurological origin
History of spinal cord trauma
Central nervous system lesions
Metabolic disease or genetic syndromes
history of abdominal surgery
History of pelvic fractures
Eurogenital Anomalies
history of taking anticholinergic drugs for six months
Psychological Disorders

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improved quality of life due to urinary incontinence three months after treatment The outcome of this study is evaluated by a standard questionnaire. Timepoint: 1 and 3 months after treatment. Method of measurement: The q-OAB questionnaire will be used to collect the frequency of urinary frequency, urgency, and urgency incontinence for 3 days. q-OAB is a quality of life questionnaire designed to assess symptoms of health-related symptoms and quality of life (HRQL) in patients with or without incontinence and OAB. q-OAB contains 4 subset include social, interaction, concern, coping and HRQL.

Secondary Outcome Measures

Name	Time	Method
Improving patients' quality of life is a secondary outcome of this study. Timepoint: 1 and 3 months after treatment onset. Method of measurement: Outcoms are measured using the summary form of the Bladder Hyperactivity Questionnaire, which contains 25 questions. The questionnaire consists of two parts: 6 questions (symptoms of bladder hyperactivity) and 19 questions (quality of life associated with bladder hyperactivity).